Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID Q92793 1387 CREBBP CBP Lung adenocarcinoma Acetylation N K13 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Acetylation N K13 Q92793 1387 CREBBP CBP Bladder urothelial carcinoma Phosphorylation N S78 Q92793 1387 CREBBP CBP Rectum adenocarcinoma Phosphorylation N S78 Q92793 1387 CREBBP CBP Transitional cell carcinoma Phosphorylation N S78 Q92793 1387 CREBBP CBP Bladder urothelial carcinoma Phosphorylation N S93 Q92793 1387 CREBBP CBP Renal cell carcinoma Phosphorylation N S93 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N S93 Q92793 1387 CREBBP CBP Colon adenocarcinoma Phosphorylation N S121 Q92793 1387 CREBBP CBP Colon adenocarcinoma Phosphorylation N S124 Q92793 1387 CREBBP CBP Cervical squamous cell carcinoma Methylation N R220 Q92793 1387 CREBBP CBP Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N R220 Q92793 1387 CREBBP CBP Dystonia Methylation N R220 Q92793 1387 CREBBP CBP Lung adenocarcinoma Methylation N R220 Q92793 1387 CREBBP CBP Intellectual disability Phosphorylation N S302 Q92793 1387 CREBBP CBP Lung adenocarcinoma Phosphorylation N S302 Q92793 1387 CREBBP CBP Neurodevelopmental disorder Phosphorylation N S302 Q92793 1387 CREBBP CBP Lung adenocarcinoma Acetylation N K389 Q92793 1387 CREBBP CBP Stomach adenocarcinoma Acetylation N K389 Q92793 1387 CREBBP CBP Colorectal cancer Methylation N R601 Q92793 1387 CREBBP CBP Hepatocellular carcinoma Methylation N R601 Q92793 1387 CREBBP CBP Melanoma Methylation N R601 Q92793 1387 CREBBP CBP Uterine cancer Methylation N R601 Q92793 1387 CREBBP CBP Head and neck squamous cell carcinoma Acetylation N K622 Q92793 1387 CREBBP CBP Skin cutaneous melanoma Acetylation N K622 Q92793 1387 CREBBP CBP Colorectal cancer Methylation N R625 Q92793 1387 CREBBP CBP Esophageal cancer Methylation N R625 Q92793 1387 CREBBP CBP Stomach cancer Methylation N R625 Q92793 1387 CREBBP CBP Uterine cancer Methylation N R625 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Acetylation N K657 Q92793 1387 CREBBP CBP Uterine cancer Acetylation N K657 Q92793 1387 CREBBP CBP Bladder urothelial carcinoma Phosphorylation N Y659 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N Y659 Q92793 1387 CREBBP CBP Bladder urothelial carcinoma Methylation N R714 Q92793 1387 CREBBP CBP Colon adenocarcinoma Methylation N R714 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Methylation N R714 Q92793 1387 CREBBP CBP Uterine corpus endometrial carcinoma Methylation N R742 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Methylation N R768 Q92793 1387 CREBBP CBP Uterine corpus endometrial carcinoma Methylation N R768 Q92793 1387 CREBBP CBP Neurodevelopmental disorder Phosphorylation N T1001 Q92793 1387 CREBBP CBP Bladder urothelial carcinoma Acetylation N K1014 Q92793 1387 CREBBP CBP Neurodevelopmental disorder Acetylation N K1014 Q92793 1387 CREBBP CBP Bladder urothelial carcinoma Phosphorylation N S1019 Q92793 1387 CREBBP CBP Head and neck squamous cell carcinoma Phosphorylation N S1019 Q92793 1387 CREBBP CBP Head and neck squamous cell carcinoma Phosphorylation N S1030 Q92793 1387 CREBBP CBP Neurodevelopmental disorder Phosphorylation N S1030 Q92793 1387 CREBBP CBP Neurodevelopmental disorder SUMOylation N K1033 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Acetylation N K1042 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N S1043 Q92793 1387 CREBBP CBP Cervical squamous cell carcinoma and endocervical adenocarcinoma SUMOylation N K1056 Q92793 1387 CREBBP CBP Lung adenocarcinoma SUMOylation N K1056 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome SUMOylation N K1056 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N T1070 Q92793 1387 CREBBP CBP Neurodevelopmental disorder Phosphorylation N S1076 Q92793 1387 CREBBP CBP Kidney renal papillary cell carcinoma Phosphorylation N Y1125 Q92793 1387 CREBBP CBP Renal cell carcinoma Phosphorylation N Y1125 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N T1171 Q92793 1387 CREBBP CBP Medulloblastoma Acetylation N K1203 Q92793 1387 CREBBP CBP Head and neck squamous cell carcinoma Methylation N R1341 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Methylation N R1341 Q92793 1387 CREBBP CBP Ovarian cancer Acetylation N K1376 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Acetylation N K1376 Q92793 1387 CREBBP CBP Neurodevelopmental disorder Phosphorylation C S1382 Q92793 1387 CREBBP CBP Ovarian cancer Phosphorylation N S1382 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N S1382 Q92793 1387 CREBBP CBP Neurodevelopmental disorder Phosphorylation C S1386 Q92793 1387 CREBBP CBP Blastoma Phosphorylation N S1386 Q92793 1387 CREBBP CBP Liver cancer Phosphorylation N S1386 Q92793 1387 CREBBP CBP Neurodevelopmental disorder Phosphorylation N S1386 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N S1386 Q92793 1387 CREBBP CBP Neurodevelopmental disorder Phosphorylation N Y1391 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N Y1450 Q92793 1387 CREBBP CBP Breast invasive carcinoma Ubiquitination N K1524 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Ubiquitination N K1524 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Acetylation N K1535 Q92793 1387 CREBBP CBP Stomach adenocarcinoma Acetylation N K1535 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Ubiquitination N K1535 Q92793 1387 CREBBP CBP Stomach adenocarcinoma Ubiquitination N K1535 Q92793 1387 CREBBP CBP Cervical squamous cell carcinoma and endocervical adenocarcinoma Acetylation N K1595 Q92793 1387 CREBBP CBP Lung adenocarcinoma Acetylation N K1595 Q92793 1387 CREBBP CBP Stomach adenocarcinoma Acetylation N K1595 Q92793 1387 CREBBP CBP Thyroid carcinoma Acetylation N K1595 Q92793 1387 CREBBP CBP Cervical squamous cell carcinoma and endocervical adenocarcinoma Acetylation N K1597 Q92793 1387 CREBBP CBP Lung adenocarcinoma Acetylation N K1597 Q92793 1387 CREBBP CBP Stomach adenocarcinoma Acetylation N K1597 Q92793 1387 CREBBP CBP Uterine corpus endometrial carcinoma Acetylation N K1597 Q92793 1387 CREBBP CBP Breast invasive carcinoma Acetylation N K1620 Q92793 1387 CREBBP CBP Head and neck squamous cell carcinoma Acetylation N K1620 Q92793 1387 CREBBP CBP Breast invasive carcinoma Acetylation N K1627 Q92793 1387 CREBBP CBP Head and neck squamous cell carcinoma Acetylation N K1627 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Acetylation N K1627 Q92793 1387 CREBBP CBP Stomach adenocarcinoma Acetylation N K1627 Q92793 1387 CREBBP CBP Bladder urothelial carcinoma Phosphorylation N T1669 Q92793 1387 CREBBP CBP Brain lower grade glioma Phosphorylation N T1669 Q92793 1387 CREBBP CBP Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T1669 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N T1669 Q92793 1387 CREBBP CBP Uterine corpus endometrial carcinoma Phosphorylation N T1669 Q92793 1387 CREBBP CBP Inborn genetic diseases Acetylation N K1711 Q92793 1387 CREBBP CBP Lung adenocarcinoma Acetylation N K1711 Q92793 1387 CREBBP CBP Menke-Hennekam syndrome Acetylation N K1711 Q92793 1387 CREBBP CBP Prostate adenocarcinoma Acetylation N K1711 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Acetylation N K1736 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Acetylation N K1741 Q92793 1387 CREBBP CBP Menke-Hennekam syndrome Acetylation N K1744 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Acetylation N K1744 Q92793 1387 CREBBP CBP Lung adenocarcinoma Phosphorylation N S1755 Q92793 1387 CREBBP CBP Lung adenocarcinoma Acetylation N K1762 Q92793 1387 CREBBP CBP Lung squamous cell carcinoma Acetylation N K1762 Q92793 1387 CREBBP CBP Lung adenocarcinoma Phosphorylation N S1763 Q92793 1387 CREBBP CBP Lung squamous cell carcinoma Phosphorylation N S1763 Q92793 1387 CREBBP CBP Lung squamous cell carcinoma Phosphorylation N S1771 Q92793 1387 CREBBP CBP Breast invasive carcinoma Phosphorylation N S1791 Q92793 1387 CREBBP CBP Colon adenocarcinoma Phosphorylation N S1791 Q92793 1387 CREBBP CBP Inborn genetic diseases Phosphorylation N S1791 Q92793 1387 CREBBP CBP Menke-Hennekam syndrome Phosphorylation N S1791 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N S1791 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Acetylation N K1797 Q92793 1387 CREBBP CBP Stomach adenocarcinoma Acetylation N K1797 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Acetylation N K1799 Q92793 1387 CREBBP CBP Stomach adenocarcinoma Acetylation N K1799 Q92793 1387 CREBBP CBP Menke-Hennekam syndrome Acetylation N K1831 Q92793 1387 CREBBP CBP Menke-Hennekam syndrome Acetylation N K1837 Q92793 1387 CREBBP CBP Menke-Hennekam syndrome Phosphorylation N T1871 Q92793 1387 CREBBP CBP Neurodevelopmental disorder Phosphorylation N T1871 Q92793 1387 CREBBP CBP Menke-Hennekam syndrome Phosphorylation N T1874 Q92793 1387 CREBBP CBP Global developmental delay Phosphorylation C S2063 Q92793 1387 CREBBP CBP Global developmental delay Phosphorylation N S2065 Q92793 1387 CREBBP CBP Uterine corpus endometrial carcinoma Phosphorylation N S2065 Q92793 1387 CREBBP CBP Uterine corpus endometrial carcinoma Phosphorylation N T2073 Q92793 1387 CREBBP CBP Uterine corpus endometrial carcinoma Ubiquitination N K2075 Q92793 1387 CREBBP CBP Colorectal cancer Phosphorylation N S2076 Q92793 1387 CREBBP CBP Uterine corpus endometrial carcinoma Phosphorylation N S2076 Q92793 1387 CREBBP CBP Uterine corpus endometrial carcinoma Phosphorylation N S2078 Q92793 1387 CREBBP CBP Melanoma Phosphorylation N S2079 Q92793 1387 CREBBP CBP Uterine corpus endometrial carcinoma Phosphorylation N S2079 Q92793 1387 CREBBP CBP Breast invasive carcinoma Ubiquitination N K2102 Q92793 1387 CREBBP CBP Skin cutaneous melanoma Ubiquitination N K2102 Q92793 1387 CREBBP CBP Uterine carcinosarcoma Ubiquitination N K2102 Q92793 1387 CREBBP CBP Uterine corpus endometrial carcinoma Ubiquitination N K2102 Q92793 1387 CREBBP CBP Skin cutaneous melanoma Phosphorylation N S2322 Q92793 1387 CREBBP CBP Hepatocellular carcinoma Phosphorylation N S2351 Q92793 1387 CREBBP CBP Lung adenocarcinoma Phosphorylation N S2351 Q92793 1387 CREBBP CBP Skin cutaneous melanoma Phosphorylation N S2351 Q92793 1387 CREBBP CBP Uterine cancer Phosphorylation N S2351 Q92793 1387 CREBBP CBP Lung adenocarcinoma Methylation N R2353 Q92793 1387 CREBBP CBP Skin cutaneous melanoma Methylation N R2353 Q92793 1387 CREBBP CBP Lung adenocarcinoma Phosphorylation N S2356 Q92793 1387 CREBBP CBP Skin cutaneous melanoma Phosphorylation N S2356 Q92793 1387 CREBBP CBP Skin cutaneous melanoma Phosphorylation N S2361 Q92793 1387 CREBBP CBP Skin cutaneous melanoma Phosphorylation N S2362 Q92793 1387 CREBBP CBP Breast invasive carcinoma Phosphorylation N S2372 Q92793 1387 CREBBP CBP Breast invasive carcinoma Phosphorylation N S2377 Q92793 1387 CREBBP CBP Lung squamous cell carcinoma Phosphorylation N S2377 Q92793 1387 CREBBP CBP Skin cutaneous melanoma Phosphorylation N S2377 Q92793 1387 CREBBP CBP Lung squamous cell carcinoma Phosphorylation N S2382 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N S2382 Q92793 1387 CREBBP CBP Skin cutaneous melanoma Phosphorylation N S2382 Q92793 1387 CREBBP CBP Lung squamous cell carcinoma Phosphorylation N T2390 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N T2390 Q92793 1387 CREBBP CBP Lung adenocarcinoma Phosphorylation N S2394 Q92793 1387 CREBBP CBP Rubinstein-Taybi syndrome Phosphorylation N S2394 Q92793 1387 CREBBP CBP Hirschsprung's disease Phosphorylation N S2406 Q92793 1387 CREBBP CBP Lung adenocarcinoma Phosphorylation N S2406 Q92793 1387 CREBBP CBP Ovarian adenocarcinoma Phosphorylation N S2406 Q92793 1387 CREBBP CBP Stomach adenocarcinoma Phosphorylation N S2422 Q92793 1387 CREBBP CBP Stomach adenocarcinoma Phosphorylation N S2425